Back to companies
Grace Therapeutics, Inc.
GRCEUSNASDAQPharmaceuticals & HealthcareGrace Therapeutics, Inc.
Revenue
—
FY2026
Operating income
-$11.1mn
FY2026
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API